FZD7: A potential biomarker for endometriosis
article
OA: gold
CC0
⤵ 3 in-corpus citations
Abstract
BACKGROUND: Endometriosis is a chronic inflammatory, benign disorder that often co-occurs with adenomyosis and/or leiomyoma. The overall incidence of endometriosis in reproductive period women was nearly 10%. However, the exact mechanisms of endometriosis-associated pathogenesis are still unknown. METHODS: In this study, we aimed to investigate whether Frizzled-7 (FZD7) would effectively promote the development of endometriosis. The microarray-based data analysis was performed to screen endometriosis-related differentially expressed genes. This process uncovered specific hub genes, and the nexus of vital genes and ferroptosis-related genes were pinpointed. Then, we collected human endometrial and endometriotic tissues from patients with endometriosis of the ovary (n = 39) and control patients without endometriosis (n = 10, who underwent hysterectomy for uterine fibroids) to compare the expression of FZD7. RESULTS: These findings indicated that the expression of FZD7 was high compared with normal endometrium, and FZD7 may promote the progression of endometriosis. CONCLUSION: FZD7 may serve as a potential therapeutic target for endometriosis treatment.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (38)
- A long-acting anti–IL-8 antibody improves inflammation and fibrosis in endometriosis via openalex
- Endometriosis via openalex
- Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis via openalex
- [Guideline for the diagnosis and treatment of endometriosis (Third edition)]. via openalex
- Loss of HDAC3 results in nonreceptive endometrium and female infertility via openalex
- MicroRNA‐488 inhibits endometrial glandular epithelial cell proliferation, migration, and invasion in endometriosis mice via Wnt by inhibiting FZD7 via openalex
- Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer via openalex
- Recent Advances in Gene Therapy of Endometriosis via openalex
- The Main Theories on the Pathogenesis of Endometriosis via openalex
- Transcript profile and localization of Wnt signaling–related molecules in human endometrium via openalex
- W2792699897 via openalex
- W2804103434 via openalex
- W2988805363 via openalex
- W3029376571 via openalex
- W3101779884 via openalex
- W3112871281 via openalex
- W3120670495 via openalex
- W3123922203 via openalex
- W3134885188 via openalex
- W3143634367 via openalex
- W3170359222 via openalex
- W4286219973 via openalex
- W4311080313 via openalex
- W4360849305 via openalex
- W4365504633 via openalex
- W6676573868 via openalex
- W6770429159 via openalex
- W1549826613 via openalex
- W6807516075 via openalex
- W1997183854 via openalex
- W2007818643 via openalex
- W2035618305 via openalex
- W2065852799 via openalex
- W2407611030 via openalex
- W2470924809 via openalex
- W2489788488 via openalex
- W2529342183 via openalex
- W2748723957 via openalex
Cited by (3)
- Silencing of FZD7 Inhibits Endometriotic Cell Viability, Migration, and Angiogenesis by Promoting Ferroptosis 2025
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis 2024
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next-generation sequencing data analysis 2024
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-06-04T00:33:28.295845+00:00
License: CC0
· commercial use OK